James D. Miller

ORCID: 0000-0002-2297-7870 · 5 papers in corpus
rct 2000
American journal of obstetrics and gynecology ·doi:10.1067/mob.2000.106846

OBJECTIVE: The purpose of this study was a quantification of changes in endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy. STUDY DESIGN: One hundred twenty wome…

other 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00166-6

OBJECTIVE: To determine the duration of time to the recurrence of pain attributable to endometriosis after the discontinuation of treatment with danazol or a GnRH agonist (GnRH-a) in patients who have had a satisfactory response to the trea…

review 1997
Advanced drug delivery reviews ·doi:10.1016/s0169-409x(97)00055-0

Uterine leiomyomata and endometriosis are two common hormone-dependent pathologies effecting women of reproductive age. Prior to the introduction of gonadotropin releasing hormone agonists (GnRHa), there was no effective medical therapy for…

rct 1992
American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(11)91718-9

OBJECTIVE: We aimed to assess the efficacy of depot leuprolide versus danazol in the treatment of endometriosis. STUDY DESIGN: A double-blind randomized trial of 270 patients from 22 centers compared the pretreatment and posttreatment lapa…

rct 1990
Fertility and sterility ·doi:10.1016/s0015-0282(16)53755-8

The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3.75 mg versus placebo, in the treatment of pain associated with endometriosis was assessed in a randomized, dou…